FDA Approves Bausch + Lomb ClearVisc™ Dispersive Ophthalmic Viscosurgical Device
News provided by
Share this article
New OVD Offers Exceptional Corneal Protection, Visibility During Ophthalmic Surgery
LAVAL, QC, April 7, 2021 /PRNewswire/ Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health ), today announced that the U.S. Food and Drug Administration (FDA) has approved ClearVisc™ dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. The ClearVisc™ dispersive OVD is the latest advancement in Bausch + Lomb s rich pipeline of ophthalmic surgical devices and is representative of our company s ongoing commitment to delivering innovations that fulfill the unmet needs of our customers, said Joe Gordon, U.S. president, Bausch + Lomb. OVDs play a critical role in cataract surgery as well as many other ophthalmic surgeries. ClearVisc™ offers significant advantages that can help surge
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share:
New York, March 11, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Advanced Ophthalmology Technologies Market Research Report by Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p06034082/?utm source=GNW
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Advanced Ophthalmology Technologies Market is expected to grow from USD 7,112.84 Million in 2020 to USD 11,324.67 Million by the end of 2025.
2. The Global Advanced Ophthalmology Technologies Market is expected to grow from EUR 6,236.67 Million in 2020 to EUR 9,929.68 Million by the end of 2025.